Top Story

World Heart Federation outlines roadmaps to reduce CVD globally

August 3, 2015

Widespread implementation of strategies to improve CV secondary prevention, hypertension and tobacco control is essential to achieve the World Heart Federation goal of achieving a 25% reduction in premature deaths from CVD worldwide by 2025, according to a new editorial in Global Heart.

During the past century, economic and nutritional improvements in many countries have significantly reduced premature deaths due to infection, undernutrition and poverty, “However, with the aging of the population and improved economic growth, diseases of undernutrition have been replaced by diseases of overnutrition in many countries, with increases in obesity, hypertension and related metabolic diseases such as CVD, diabetes and cancers — collectively termed noncommunicable diseases,” wrote World Heart Federation president Salim Yusuf, MD, of McMaster University in Hamilton, Ontario, Canada; president-elect David Wood, MSc, of Imperial College London; Pablo Perel, MD, PhD, of the World Heart Federation and the London School of Hygiene and Tropical Medicine; and Cardiology Today Editorial Board member Jagat Narula, MD, of Icahn School of Medicine at Mount Sinai Hospital, New York.

In the Journals

Stress testing after PCI varies across VA hospitals

August 3, 2015
Of more than 10,000 patients who underwent PCI at Veterans Affairs hospitals, only 22% had a stress test within 1 year and 38% within 2 years, researchers reported in a…

BLOG: Patient financing also can be used as a marketing tool

August 3, 2015
I speak with health care practices on a regular basis. During these conversations, physicians usually ask a range of questions to help determine whether they should…

Enrollment begins for two trials of dabigatran

August 2, 2015
The first U.S. patients have been enrolled in the RE-DUAL PCI and RE-CIRCUIT trials of the safety and efficacy of dabigatran in patients with nonvalvular atrial…

Trial assessing drug-coated balloon for PAD underway

August 1, 2015
The Spectranetics Corporation announced that enrollment is completed for the ILLUMNENATE Pivotal trial, which is evaluating the use of a drug-coated angioplasty balloon…
More News Headlines »
Cardiology Case Consults

The Patient With Idiopathic Pulmonary Fibrosis

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with idiopathic pulmonary fibrosis.
More »
VIDEO: Joseph Rossano, MD, MS, discusses benefits of VADs for children with advanced HF

VIDEO: Joseph Rossano, MD, MS, discusses benefits of VADs for children with advanced HF

July 17, 2015
PHILADELPHIA — In this video, Joseph Rossano, MD, MS, FAAP, FAAC, medical director of HF/transplantation at…
More »
Oral Antiplatelet Therapy in a Patient with Acute Coronary Syndrome and Percutaneous Coronary Intervention

Case Study: Oral Antiplatelet Therapy in a Patient with ACS and PCI

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC

It is estimated that in the United States, over 780,000 persons annually will experience an acute coronary syndrome…
More »